These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 12707631)

  • 1. The role of stimulating, function-blocking and growth-blocking anti-TSH receptor antibodies (TRAbs) in GD, Hashimoto's disease and in atrophic thyroiditis.
    Orgiazzi J; Madec AM; Ducottet X
    Ann Endocrinol (Paris); 2003 Feb; 64(1):31-6. PubMed ID: 12707631
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-TSH receptor antibodies in clinical practice.
    Orgiazzi J
    Endocrinol Metab Clin North Am; 2000 Jun; 29(2):339-55, vii. PubMed ID: 10874533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of cells expressing the human thyrotropin (TSH) receptor for the measurement of thyroid stimulating and TSH-blocking antibodies.
    Vitti P; Chiovato L; Fiore E; Mammoli C; Rocchi R; Pinchera A
    Acta Med Austriaca; 1996; 23(1-2):52-6. PubMed ID: 8767515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of antipituitary antibodies in patients with autoimmune thyroid disease.
    Nishino M; Yabe S; Murakami M; Kanda T; Kobayashi I
    Endocr J; 2001 Apr; 48(2):185-91. PubMed ID: 11456266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of a bioassay with CHO cells for the routine detection of stimulating and blocking autoantibodies to the TSH-receptor.
    Morgenthaler NG; Pampel I; Aust G; Seissler J; Scherbaum WA
    Horm Metab Res; 1998 Mar; 30(3):162-8. PubMed ID: 9566861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical utility of autoantibodies directed against TSH-R.
    Rocchi R
    MLO Med Lab Obs; 2005 Apr; 37(4):10-1, 14-5; quiz 16-7. PubMed ID: 15895773
    [No Abstract]   [Full Text] [Related]  

  • 7. Hyperthyroidism in an infant of a mother with autoimmune hypothyroidism with positive TSH receptor antibodies.
    Joshi K; Zacharin M
    J Pediatr Endocrinol Metab; 2018 Apr; 31(5):577-580. PubMed ID: 29494342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistence of thyrotropin (TSH) receptor antibodies in children and adolescents with Graves' disease treated using antithyroid medication.
    Smith J; Brown RS
    Thyroid; 2007 Nov; 17(11):1103-7. PubMed ID: 17822376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulating and blocking thyroid-stimulating hormone (TSH) receptor autoantibodies from patients with Graves' disease and autoimmune hypothyroidism have very similar concentration, TSH receptor affinity, and binding sites.
    Morgenthaler NG; Ho SC; Minich WB
    J Clin Endocrinol Metab; 2007 Mar; 92(3):1058-65. PubMed ID: 17179194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hashimoto's thyroiditis with heterogeneous antithyrotropin receptor antibodies: unique epitopes may contribute to the regulation of thyroid function by the antibodies.
    Akamizu T; Kohn LD; Hiratani H; Saijo M; Tahara K; Nakao K
    J Clin Endocrinol Metab; 2000 Jun; 85(6):2116-21. PubMed ID: 10852437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyrotropin receptor autoantibodies (TSHRAbs): epitopes, origins and clinical significance.
    Kohn LD; Harii N
    Autoimmunity; 2003; 36(6-7):331-7. PubMed ID: 14669940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding, stimulating and blocking TSH receptor antibodies to the thyrotropin receptor as predictors of relapse of Graves' disease after withdrawal of antithyroid treatment.
    Quadbeck B; Hoermann R; Hahn S; Roggenbuck U; Mann K; Janssen OE
    Horm Metab Res; 2005 Dec; 37(12):745-50. PubMed ID: 16372228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Graves' disease in clinical perspective.
    Ehlers M; Schott M; Allelein S
    Front Biosci (Landmark Ed); 2019 Jan; 24(1):35-47. PubMed ID: 30468646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in TSH receptor antibody levels (TRAb) as markers of effectiveness of various therapies in Graves-Basedow's disease.
    Bojarska-Szmygin A; Janicki K; Pietura R; Janicka L
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):248-53. PubMed ID: 15314994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Significance of combining tests of thyroid autoantibodies in differential diagnosis between Graves's disease and Hashimoto's hyperthyroidism].
    Hu YM; Liu W; Lu GH
    Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(11):940-2. PubMed ID: 12899792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epitope mapping of tsh receptor-blocking antibodies in Graves' disease that appear during pregnancy.
    Kung AW; Lau KS; Kohn LD
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3647-53. PubMed ID: 11502791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Graves' disease].
    Izumi Y; Amino N
    Ryoikibetsu Shokogun Shirizu; 2000; (31):92-5. PubMed ID: 11269198
    [No Abstract]   [Full Text] [Related]  

  • 18. TSH-receptor autoimmunity in Graves' disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study.
    Laurberg P; Wallin G; Tallstedt L; Abraham-Nordling M; Lundell G; Tørring O
    Eur J Endocrinol; 2008 Jan; 158(1):69-75. PubMed ID: 18166819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Autoimmune thyroid disease].
    Hidaka Y
    Nihon Rinsho; 2005 May; 63 Suppl 5():535-9. PubMed ID: 15954406
    [No Abstract]   [Full Text] [Related]  

  • 20. Heterogeneity of TSH receptor-binding antibodies in Hashimoto's thyroiditis and Graves' disease.
    De Bruin TW; Braverman LE; Brown RS
    Am J Med Sci; 1990 May; 299(5):291-7. PubMed ID: 2337120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.